Decades-Long Study Links Lifestyle to Fewer Diseases

When a clinical trial that began as a bid to stop diabetes turns into a roadmap for healthier aging, you pay attention. That is what the Diabetes Prevention Program and its long-term follow-up, the Diabetes Prevention Program Outcomes Study, have delivered after tracking thousands of participants for more than twenty years.

Researchers re-examined the records of 1,173 people who entered the original trial with prediabetes. Participants had been assigned to one of three groups: a daily placebo, daily metformin, or an intensive lifestyle program aimed at at least seven percent weight loss through diet and exercise. Those interventions were concentrated in the first three years, but the health of the cohort was monitored for decades.

What stands out is not just a reduction in new diabetes cases. It is the broader pattern. People who followed the lifestyle program were substantially less likely to accumulate multiple chronic conditions as they aged. In plain terms, eating better, moving more, and losing modest weight seemed to delay or reduce the clustering of diseases that often marks later life.

How big was the effect and what did researchers measure

Over the full follow-up period, participants who had been in the lifestyle arm experienced a 21 percent lower risk of developing multimorbidity compared with those originally assigned to placebo. Multimorbidity here meant having two or more chronic conditions. The lifestyle advantage held even when diabetes itself was removed from the list of conditions under study.

The diet and exercise group were less likely to develop multiple chronic conditions.

The team looked for 15 chronic problems commonly linked with aging. These included high blood pressure, heart failure, coronary artery disease, arrhythmias, raised cholesterol, stroke, arthritis, asthma, cancer, chronic kidney disease, chronic obstructive pulmonary disease, dementia including Alzheimer disease, depression, osteoporosis, and diabetes. The analysis adjusted for likely confounders such as age, sex, race and ethnicity, alcohol use, and body mass index to isolate the association between the early interventions and later outcomes.

Not every arm moved in the same direction. Compared with placebo there was little difference in later multimorbidity for the group that received metformin, underscoring that the extra benefit appeared most strongly tied to the lifestyle changes rather than the medication.

Still, the picture is sobering. Across the entire cohort, including those offered the lifestyle program, 85 percent developed at least two chronic conditions during follow-up. Longer lives are not automatically healthier lives. The study reframes a key public health question: how do we compress disease into a shorter span at the end of life rather than stretching poor health over many years?

Implications for public health and clinical practice

Prevention has a payoff that reaches beyond a single diagnosis. Marcel Salive of the National Institute on Aging summed this up, noting that while stopping diabetes is vital, slowing the accumulation of multiple chronic diseases may have even broader implications for quality of life, independence, and healthcare spending. Those are the outcomes that matter to patients, families, and health systems alike.

Policymakers, clinicians, and public health planners face a choice. Invest in programs that drive sustained behavioral change or lean more heavily on medical treatments after diseases have already emerged. This study makes a persuasive case for stronger investments in prevention—especially programs that help people achieve modest, durable weight loss alongside improved diet and regular physical activity.

The research appears in JAMA, and the authors are cautious about causation. Observational follow-up after a randomized trial carries limits. Even so, the long-term associations are robust and consistent enough to inform practice and policy.

Expert Insight

Dr. Lena Ortiz, a geriatrician and professor of population health, offered a pragmatic read: "Small changes compound. A seven percent reduction in body weight does not sound dramatic, but combined with improved diet and daily movement it can translate into years of better functioning. That is what patients tell me: they care about mobility, clarity of mind, and independence more than single lab values."

Her comment highlights a point researchers stress: lifestyle programs can be scaled, adapted, and delivered through community health systems. The barrier is often not evidence but access and sustained support.

Conclusion

The Diabetes Prevention Program and its long-term follow-up show that an early, intensive lifestyle intervention can have echoes across decades. The takeaway is pragmatic. Encouraging healthy eating, regular physical activity, and achievable weight loss in midlife can reduce the burden of multiple chronic diseases later on. For individuals and for systems strained by rising chronic disease rates, the findings are a reminder that prevention is an investment with long-term returns.